Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Covance
Covance
Activities:
Research & Development
X
LinkedIn
Trending Articles
Fluidic Sciences relaunches Microfluidic Diffusional Sizing technology to refine protein-protein interaction analysis
The Microfluidic Diffusional Sizing (MDS) technology allows scientists better options when characterising a protein's biophysical properties
Cost, compliance and quality: the benefits of outsourcing to India
With pressure to find the next blockbuster drug mounting, pharmaceutical companies in the 1990s took advantage of lower-cost outsourcing options to target multiple drug...
Reducing a chemical manufacturing plant’s energy demand
The industrial sector has historically associated energy efficiency with making incremental improvements to thermal utility systems. Typical gains and carbon dioxide reductions...
AstraZeneca & Daiichi Sankyo's Enhertu bags another approval for gastric cancer applications
The HER2-targeting ADC has received conditional approval owing to the results of the DESTINY-Gastric06 Phase II trial
DFE Pharma opens Indian OSD-focused pharma support centre
The company has planned to provide services that are mainly focus on oral solid dosage (OSD) forms and comprise a range of pre-registration work including development,...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Media
Pharma outsourcing mergers and acquisitions set for record year in 2015
Value of pharmaceutical outsourcing merger and acquisition deals has more than doubled from US$5.5bn in 2014 to $12bn by October 2015
You need to be a subscriber to read this article.
Click here
to find out more.
Research & Development
Focus turns to pre-empting disease causes and ageing
Drug discovery is brimming with innovation and technology but success is still seldom and slow. Susan Birks reports on the changing discovery landscape and how the odds can be improved
Manufacturing
Covance expands global biologics capabilities
New investments in facilities and scientific leadership reflect commitment to biologics development
Analysis
Covance and PathoQuest collaborate on NGS-based biosafety assessments
Innovative biosafety testing approach provides a flexible testing solution to all biotherapeutic clients
Regulatory
Covance and Indiana Clinical and Translational Sciences Institute to conduct early clinical trials
Two organisations will conduct high-quality research in a safe and regulated environment for sponsors who are looking to recruit both healthy volunteers and patients
Regulatory
Steve Street joins Covance
Will oversee worldwide safety assessment and pharmaceutical chemistry services
Finance
Covance and sanofi-aventis finalise r&d alliance
Covance also acquires sanofi-aventis plants in France and the UK
Subscribe now